New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

New Pill Could Replace Gastric Bypass Surgery

A team of researchers from Brigham and Women’s Hospital has developed a pill that could yield the same benefits of gastric bypass surgery and reverse type 2 diabetes.

Bypass Pill / Image: Randal McKenzie
Bypass Pill / Image: Randal McKenzie

Type 2 diabetes is a curable disease, and the solution is gastric bypass surgery. A study of 20,000 patients who had undergone the procedure showed that 84% of them were completely cured of their type 2 diabetes. However, there are a range of side effects associated with reducing the size of a patients’ stomach including hernias, infection, blood clots, ulcers, or even death.

A recent Futurism article discussed a new development that cold yield the same benefits of gastric bypass surgery without the surgery part. A team of researchers at Brigham and Women’s Hospital believes that weight loss isn’t necessarily the key to curing type 2 diabetes. They’ve developed a compound they call LuCl (Luminal Coating of the Intestine) using an FDA-approved drug called sucralfate as a base. The compound temporarily coats the lining of the intestine and makes it unable to absorb nutrients.

LuCl seems to work; it lowered post-meal response to glucose in rats by 47%. The next step is to test LuCl on diabetic and obese rats.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub